Pituitary Physiology and Endocrinology

Chapter

Abstract

The hypothalamic-pituitary unit plays a vital role in several crucial bodily functions. The hypothalamus integrates stimuli from a wide array of sources to control behavioral, metabolic, and autonomic processes. Homeostatic mechanisms governed by the hypothalamus include water metabolism, appetite control, temperature regulation, sleep-wake cycles, and autonomic functions. It also plays a role in memory, behavior, and emotions. Importantly, the hypothalamus regulates the production and secretion of pituitary hormones. Through this function, it serves a critical role in the integration of neural and hormonal activity.

The pituitary gland, under control from peripheral hormonal feedback, intrapituitary paracrine action, and hypothalamic signaling, has a profound role in the endocrine and metabolic function of the body.

Keywords

Pituitary Hypothalamus Hypophysiotropic endocrinology 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Melmed S, Kleinberg DL, Ho K. Pituitary physiology and diagnostic evaluation. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology. 12th ed. Philadelphia: Saunders; 2011. p. 175–228.CrossRefGoogle Scholar
  2. 2.
    Ben-Shlomo A, Melmed S. Regulation of anterior pituitary function. In: Melmed S, editor. The pituitary. 3rd ed. Waltham: Academic; 2011. p. 21–45.CrossRefGoogle Scholar
  3. 3.
    Thackray VG, Mellon PL, Coss D. Hormones in synergy: regulation of the pituitary gonadotropin genes. Mol Cell Endocrinol. 2010;314:192–203.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Vadakkadath Meethal S, Atwood CS. The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain. Cell Mol Life Sci. 2005;62:257–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Quintanar JL, Guzman-Soto I. Hypothalamic neurohormones and immune responses. Front Integr Neurosci. 2013;7:56.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Matsumoto AM, Bremner WJ. Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab. 1984;58:609–14.CrossRefPubMedGoogle Scholar
  7. 7.
    Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley Jr WF. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85:3027–35.PubMedGoogle Scholar
  8. 8.
    O’Connor AE, De Kretser DM. Inhibins in normal male physiology. Semin Reprod Med. 2004;22:177–85.CrossRefPubMedGoogle Scholar
  9. 9.
    Hall JE, Schoenfeld DA, Martin KA, Crowley Jr WF. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab. 1992;74:600–7.PubMedGoogle Scholar
  10. 10.
    Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest. 1975;55:699–706.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Adams JM, Taylor AE, Schoenfeld DA, Crowley Jr WF, Hall JE. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab. 1994;79:858–64.PubMedGoogle Scholar
  12. 12.
    Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev. 2007;28:117–49.CrossRefPubMedGoogle Scholar
  13. 13.
    Gutierrez-Pascual E, Martinez-Fuentes AJ, Pinilla L, Tena-Sempere M, Malagon MM, Castano JP. Direct pituitary effects of kisspeptin: activation of gonadotrophs and somatotrophs and stimulation of luteinising hormone and growth hormone secretion. J Neuroendocrinol. 2007;19:521–30.CrossRefPubMedGoogle Scholar
  14. 14.
    Moschos S, Chan JL, Mantzoros CS. Leptin and reproduction: a review. Fertil Steril. 2002;77:433–44.CrossRefPubMedGoogle Scholar
  15. 15.
    Costa-e-Sousa RH, Hollenberg AN. Minireview: the neural regulation of the hypothalamic-pituitary-thyroid axis. Endocrinology. 2012;153:4128–35.PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Colaianni G, Cuscito C, Colucci S. FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis. Clin Dev Immunol. 2013;2013:382698.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Moura EG, Moura CC. Regulation of thyrotropin synthesis and secretion. Arq Bras Endocrinol Metabol. 2004;48:40–52.CrossRefPubMedGoogle Scholar
  18. 18.
    Mebis L, van den Berghe G. The hypothalamus-pituitary-thyroid axis in critical illness. Neth J Med. 2009;67:332–40.PubMedGoogle Scholar
  19. 19.
    Mebis L, Debaveye Y, Visser TJ, Van den Berghe G. Changes within the thyroid axis during the course of critical illness. Endocrinol Metab Clin North Am. 2006;35:807–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Veldhuis JD. Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol. 2013;9:205–15.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Fisher DA. Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clin Chem. 1996;42:135–9.PubMedGoogle Scholar
  22. 22.
    Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab. 2011;301:E567–84.PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Guillemin R. Hypothalamic hormones a.k.a. hypothalamic releasing factors. J Endocrinol. 2005;184:11–28.CrossRefPubMedGoogle Scholar
  24. 24.
    Cooper DS, Ridgway EC, Kliman B, Kjellberg RN, Maloof F. Metabolic clearance and production rates of prolactin in man. J Clin Invest. 1979;64:1669–80.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Veldhuis JD, Johnson ML. Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab. 1988;67:116–23.CrossRefPubMedGoogle Scholar
  26. 26.
    Greenspan SL, Klibanski A, Rowe JW, Elahi D. Age alters pulsatile prolactin release: influence of dopaminergic inhibition. Am J Physiol. 1990;258:E799–804.PubMedGoogle Scholar
  27. 27.
    Ignacak A, Kasztelnik M, Sliwa T, Korbut RA, Rajda K, Guzik TJ. Prolactin–not only lactotrophin. A “new” view of the “old” hormone. J Physiol Pharmacol. 2012;63:435–43.PubMedGoogle Scholar
  28. 28.
    Horseman ND, Gregerson KA. Prolactin actions. J Mol Endocrinol. 2014;52:R95–106.CrossRefPubMedGoogle Scholar
  29. 29.
    Serri O, Chik CL, Ur E, Ezzat S. Diagnosis and management of hyperprolactinemia. CMAJ. 2003;169:575–81.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev. 1993;14:20–39.CrossRefPubMedGoogle Scholar
  31. 31.
    Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19:717–97.PubMedGoogle Scholar
  32. 32.
    Reichlin S. Somatostatin. N Engl J Med. 1983;309:1495–501.CrossRefPubMedGoogle Scholar
  33. 33.
    Reichlin S. Somatostatin (second of two parts). N Engl J Med. 1983;309:1556–63.CrossRefPubMedGoogle Scholar
  34. 34.
    Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16:3–34.PubMedGoogle Scholar
  35. 35.
    Zadik Z, Chalew SA, McCarter Jr RJ, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 1985;60:513–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Vahl N, Jorgenson JO, Jurik AG, Christiansen JS. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J Clin Endocrinol Metab. 1996;81:2209–15.PubMedGoogle Scholar
  37. 37.
    Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism. 1994;43:315–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Takahashi Y. Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J. 2012;59:955–62.CrossRefPubMedGoogle Scholar
  39. 39.
    Brick DJ, Gerweck AV, Meenaghan E, Lawson EA, Misra M, Fazeli P, et al. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. Eur J Endocrinol. 2010;163:185–91.PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B, et al. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J Clin Endocrinol Metab. 1987;65:634–42.CrossRefPubMedGoogle Scholar
  41. 41.
    Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273:974–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRefPubMedGoogle Scholar
  43. 43.
    Smith RG, Jiang H, Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol Metab. 2005;16:436–42.CrossRefPubMedGoogle Scholar
  44. 44.
    Moller N, Jorgenson JO, Abildgard N, Orskov L, Schmitz O, Christiansen JS. Effects of growth hormone on glucose metabolism. Horm Res. 1991;36 Suppl 1:32–5.PubMedGoogle Scholar
  45. 45.
    Roth J, Glick SM, Yalow RS, Berson SA. The influence of blood glucose on the plasma concentration of growth hormone. Diabetes. 1964;13:355–61.CrossRefPubMedGoogle Scholar
  46. 46.
    Earll JM, Sparks LL, Forsham PH. Glucose suppression of serum growth hormone in the diagnosis of acromegaly. JAMA. 1967;201:628–30.CrossRefPubMedGoogle Scholar
  47. 47.
    Buonomo FC, Baile CA. The neurophysiological regulation of growth hormone secretion. Domest Anim Endocrinol. 1990;7:435–50.CrossRefPubMedGoogle Scholar
  48. 48.
    de Boer H, Blok GJ, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 1995;16:63–86.CrossRefPubMedGoogle Scholar
  49. 49.
    Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009;119:3189–202.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
    Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004;44:525–57.CrossRefPubMedGoogle Scholar
  51. 51.
    Keeney DS, Waterman MR. Regulation of steroid hydroxylase gene expression: importance to physiology and disease. Pharmacol Ther. 1993;58:301–17.CrossRefPubMedGoogle Scholar
  52. 52.
    Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev. 1984;5:1–24.CrossRefPubMedGoogle Scholar
  53. 53.
    Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005;90:3106–14.CrossRefPubMedGoogle Scholar
  54. 54.
    Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. J Clin Endocrinol Metab. 1993;77:173–7.PubMedGoogle Scholar
  55. 55.
    Veldhuis JD, Sharma A, Roelfsema F. Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol Metab Clin North Am. 2013;42:201–25.PubMedCentralCrossRefPubMedGoogle Scholar
  56. 56.
    Aguilera G. HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol. 2011;46:90–5.PubMedCentralCrossRefPubMedGoogle Scholar
  57. 57.
    Kanaley JA, Weltman JY, Pieper KS, Weltman A, Hartman ML. Cortisol and growth hormone responses to exercise at different times of day. J Clin Endocrinol Metab. 2001;86:2881–9.PubMedGoogle Scholar
  58. 58.
    Donaldson ZR, Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science. 2008;322:900–4.CrossRefPubMedGoogle Scholar
  59. 59.
    Braunstein G. The hypothalamus. In: Melmed S, editor. The pituitary. 3rd ed. Waltham: Academic; 2011. p. 303–37.CrossRefGoogle Scholar
  60. 60.
    Yang HP, Wang L, Han L, Wang SC. Nonsocial functions of hypothalamic oxytocin. ISRN Neurosci. 2013;2013:179272.PubMedCentralCrossRefPubMedGoogle Scholar
  61. 61.
    Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y, et al. Aquaporin water channels–from atomic structure to clinical medicine. J Physiol. 2002;542:3–16.PubMedCentralCrossRefPubMedGoogle Scholar
  62. 62.
    Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, et al. REVIEW: oxytocin: crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther. 2010;16:e138–56.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Division of Endocrinology and Diabetes, Department of MedicineLos Angeles County/University of Southern California Medical CenterLos AngelesUSA
  2. 2.Division of Endocrinology and Diabetes, Department of MedicineUniversity of Southern California Pituitary CenterLos AngelesUSA

Personalised recommendations